, Tracking Stock Market Picks
Enter Symbol:
Orasure Technologies, Inc. (OSUR) [hlAlert]

up 16.92 %

Orasure Technologies, Inc. (OSUR) upgraded to Buy with price target $5.50 by Needham

Posted on: Tuesday,  Nov 17, 2009  8:25 AM ET by Needham

Needham rated Buy Orasure Technologies, Inc. (NASDAQ: OSUR) on 11/17/2009, when the stock price was $4.49. Since
then, Orasure Technologies, Inc. has gained 16.93% as of 01/13/2016's recent price of $5.25.
If you would have followed this Needham's recommendation on OSUR, you would have gained 16.92% of your investment in 2248 days.

Orasure Technologies, Inc. develops, manufactures, markets and sells oral fluid diagnostic products and specimen collection devices using its own oral fluid technologies, as well as diagnostic products, including immunoassays and other in vitro diagnostic tests and other medical services. The Company?s diagnostic products include tests, which are processed in a laboratory. These products are sold in the United States and internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physician?s offices, and commercial and industrial entities.

Needham & Company, LLC focuses on emerging growth companies in technology, biotechnology and life sciences. The firm's research goal is to service the needs of growth-oriented institutional clients. Needham & Company has established itself as a premier specialty investment bank providing timely and valuable analysis on companies that are under-covered by the majority of Wall Street firms.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/17/2009 8:25 AM Buy
4.49 5.50
as of 12/31/2009
1 Week up  34.19 %
1 Month up  75.78 %
3 Months up  50.33 %
1 YTD up  50.33 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/20/2008 9:25 AM Hold
5/7/2008 9:25 AM Buy
5.88 10.00
10/15/2007 9:25 AM Buy
10.22 14.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy